5/22
08:12 am
drrx
DURECT Co. (NASDAQ: DRRX) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
Low
Report
DURECT Co. (NASDAQ: DRRX) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
5/22
03:06 am
drrx
DURECT Co. (NASDAQ: DRRX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Neutral
Report
DURECT Co. (NASDAQ: DRRX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
5/22
03:06 am
drrx
DURECT Co. (NASDAQ: DRRX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Neutral
Report
DURECT Co. (NASDAQ: DRRX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
5/21
08:11 am
drrx
DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis [Yahoo! Finance]
High
Report
DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis [Yahoo! Finance]
5/21
08:00 am
drrx
DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis
Neutral
Report
DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis
5/15
10:57 am
drrx
DURECT Co. (NASDAQ: DRRX) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
Medium
Report
DURECT Co. (NASDAQ: DRRX) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
5/15
12:06 am
drrx
DURECT Co. (NASDAQ: DRRX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
DURECT Co. (NASDAQ: DRRX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
5/13
04:05 pm
drrx
DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update
High
Report
DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update
5/7
04:30 pm
drrx
DURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business Update
High
Report
DURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business Update
4/30
07:00 am
drrx
DURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated Hepatitis
Low
Report
DURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated Hepatitis
4/1
02:22 pm
drrx
DURECT Corporation (NASDAQ:DRRX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
DURECT Corporation (NASDAQ:DRRX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
4/1
10:15 am
drrx
DURECT Co. (NASDAQ: DRRX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $5.00 price target on the stock.
Low
Report
DURECT Co. (NASDAQ: DRRX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $5.00 price target on the stock.
3/28
11:03 pm
drrx
DURECT Co. (NASDAQ: DRRX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Medium
Report
DURECT Co. (NASDAQ: DRRX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
3/28
08:24 am
drrx
DURECT Co. (NASDAQ: DRRX) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
High
Report
DURECT Co. (NASDAQ: DRRX) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
3/27
06:24 pm
drrx
Durect (DRRX) Reports Q4 Loss, Misses Revenue Estimates [Yahoo! Finance]
Medium
Report
Durect (DRRX) Reports Q4 Loss, Misses Revenue Estimates [Yahoo! Finance]
3/27
04:09 pm
drrx
DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
3/27
04:01 pm
drrx
DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Medium
Report
DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
3/20
04:39 pm
drrx
DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update [Yahoo! Finance]
Low
Report
DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update [Yahoo! Finance]
3/20
04:30 pm
drrx
DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update
Low
Report
DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update
3/19
02:09 am
drrx
DURECT Co. (NASDAQ: DRRX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
DURECT Co. (NASDAQ: DRRX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
3/11
02:05 am
drrx
DURECT Co. (NASDAQ: DRRX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Neutral
Report
DURECT Co. (NASDAQ: DRRX) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.